HPR10 Added Benefit and Revenues of Oncology Drugs Approved By the European Medicines Agency between 1995 and 2020
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1329
https://www.valueinhealthjournal.com/article/S1098-3015(23)04459-5/fulltext
Title :
HPR10 Added Benefit and Revenues of Oncology Drugs Approved By the European Medicines Agency between 1995 and 2020
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04459-5&doi=10.1016/j.jval.2023.09.1329
First page :
Section Title :
Open access? :
No
Section Order :
10800